Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s1590-8658(00)80277-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Molecular Diagnosis of Endosymbiont in -Positive Samples in Laboratory Conditions and in the Hospital Environments.
Iran J Parasitol
January 2024
Department of Microbiology, Arak University of Medical Sciences, Arak, Iran.
Background: We aimed to identity endosymbiont in -positive samples in natural and laboratory conditions.
Methods: Overall, 134 samples were collected from hospital environments. Microscopic and PCR test were used for detection of and The real-time PCR method was used to check the active presence of within under natural conditions from hospital samples and in co-culture laboratory conditions.
Revaluation of 's role in esophageal carcinoma: A call for comprehensive research.
World J Gastroenterol
December 2024
Department of Surgery, Assab Military Hospital, Assab 291-1, Southern Red-sea Region, Eritrea.
The study by López-Gómez , reports a significantly low prevalence (4.5%) of () infection in esophageal cancer patients, contrasting sharply with the general population's infection rate. This finding challenges the established negative association between and gastric malignancies, suggesting a potential protective role of against esophageal carcinoma, particularly in the context of widespread proton pump inhibitor use.
View Article and Find Full Text PDFValue of serum pepsinogen ratio screening for early gastric cancer and precancerous lesions in Youcheng area.
World J Gastrointest Surg
December 2024
Health Management Center, Shengli Oilfield Central Hospital, Dongying 257000, Shandong Province, China.
Background: The 5-year survival rate of patients with advanced gastric cancer remains extremely low (< 15%), whereas the 5-year survival rate of patients with early gastric cancer (EGC) is > 90%. Consequently, strengthening the screening of patients with EGC and precancerous lesions (PCLs) is essential.
Aim: To identify the value of serum pepsinogen ratio (PGR) screening for EGC and PCLs in the Shengli Oilfield Central Hospital.
A History of the Discovery of Helicobacter Pylori, with Special Reference to Giulio Bizzozero.
J Gastrointestin Liver Dis
December 2024
Lynda K and David M Underwood Center for Digestive Disorders, Houston Methodist Hospital and Weill Cornell Medical College, Houston, Texas, USA.
Helicobacter pylori is a microorganism that is highly prevalent in mankind and closely linked to several gastroduodenal disorders. Though Helicobacter pylori was introduced to the scientific community in 1983 by Robin Warren and Barry Marshall, a closely related Helicobacter species had been described one hundred years earlier by the Italian pathologist Giulio Bizzozero in the canine stomach. In this review we analyze the different steps involved in the discovery of Helicobacter and provide a biography of the pioneer Giulio Bizzozero.
View Article and Find Full Text PDFUpdating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy.
J Gastrointestin Liver Dis
December 2024
Department of Medical and Surgical Sciences, IRCCS St. Orsola Polyclinic, University of Bologna, Bologna; Department of Cardiovascular Medicine Unit, Heart, Chest and Vascular, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Background And Aims: Bacterial resistance toward the most used antibiotics is increasing in Helicobacter pylori (H. pylori) strains worldwide. The emergence of multidrug resistance significantly affects the efficacy of standard therapy regimens.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!